Results 51 to 60 of about 16,120 (198)

Human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis co-infections among patients with anogenital warts in Tabriz, Iran [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2018
Introduction: Genital infection with papilloma virus is the most common sexually-transmitted disease (STD). It is recommended that individuals who have a sexual risk factor, should be screened for syphilis, human immunodeficiency virus (HIV), and ...
Sara Saniee   +11 more
doaj   +1 more source

HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal   +2 more
wiley   +1 more source

Update on the treatment of genital warts [PDF]

open access: yes, 2013
This review summarizes new treatments from the last seven years employed for the treatment of genital warts caused by human papillomavirus (HPV). Imquimod 3.75% is a new agent with fewer side effects and perhaps a better dosing schedule than imquimod 5%,
Scheinfeld, Noah, Scheinfeld, Noah,
core   +1 more source

Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
This study demonstrates that women's experiences following an hrHPV diagnosis within cervical screening extend beyond individual reactions to medical information, encompassing complex psychological, social, and cultural dimensions that influence how women interpret and manage the diagnosis.
Joan Hansen   +6 more
wiley   +1 more source

What can surveillance of genital warts tell us? [PDF]

open access: yes, 2010
In this Review, we describe the recent epidemiology of genital warts and postulate what the future may hold as a result of the introduction of the quadrivalent human papillomavirus (HPV) vaccine.
Basil Donovan, Christopher K. Fairley
core   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann   +7 more
wiley   +1 more source

Treatment patterns and associated costs for genital warts in Italy [PDF]

open access: yes, 2008
Objective: Genital warts are caused by human papillomavirus (HPV), principally types 6 and 11, and are highly contagious. This study assessed treatment patterns and costs of management of genital warts in Italy.
Naldi L.   +7 more
core   +1 more source

Human Papillomaviruses in Buschke-Lowenstein Tumors: Physical State of the DNA and Identification of a Tandem Duplication in the Noncoding Region of a Human Papillomavirus 6 Subtype [PDF]

open access: yes, 1986
Six Buschke-Löwenstein tumors, i.e., highly differentiated squamous cell tumors of the genital region, were shown to contain human papillomavirus 6 (HPV 6) or HPV 11 genomes.
Boshart, Michael, Hausen, Harald zur
core  

Burden of genital warts in Ecuador

open access: yesDST, 2019
Introduction: Human papillomavirus types 6 and 11 cause 90% of genital warts. Although the epidemiology of cervical cancer and the distribution of human papillomavirus genotypes have been investigated in Ecuador, little is known about the occurrence of ...
Hector Zambrano   +6 more
doaj  

Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]

open access: yes, 2008
OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy